Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.63 -0.02 (-3.58%)
At close: Oct 1, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Long-Term Investments (2013)

Updated

Biodexa Pharmaceuticals' Long-Term Investments came in at $19,429 for the quarter ended Dec 31, 2013.

Analysis

Biodexa Pharmaceuticals (BDRX) Long-Term Investments (2013) Analysis & Trends

As of Dec 31, 2013, Biodexa Pharmaceuticals' Long-Term Investments was $18,778.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Biodexa Pharmaceuticals 41.69 Mn 18.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 19,428.88
API Access

Biodexa Pharmaceuticals Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BDRX&period=max&api_key=YOUR_API_KEY